Total operating expenditure for the period under review was Rs 1,228.66 crore, up 4.5% YoY.

Profit before tax in Q4 FY26 stood at Rs 531.23 crore, up by 10.1% from Rs 482.71 crore in Q4 FY25.

For FY26, the company has recorded net profit and revenue from operations of Rs 1552.02 crore (up 9.7% YoY) and Rs 6,929.05 crore (up 8.1% YoY), respectively.

Abbott India is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India.

The scrip fell 1.99% to currently trade at Rs 27224.40 on the BSE.